Truscreen Group Ltd
TruScreen Group Limited, together with its subsidiaries, develops, manufacture, and sale of cancer detection devices and systems in Mexico, China, Russia, Vietnam, Zimbabwe, and the Middle East/North Africa. It offers the TruScreen cervical cancer screening device, a medical device for identifying and detecting the presence of precancerous and cancerous tissue on the cervix in real time. The comp… Read more
Truscreen Group Ltd (TRU) - Total Assets
Latest total assets as of September 2025: AU$4.30 Million AUD
Based on the latest financial reports, Truscreen Group Ltd (TRU) holds total assets worth AU$4.30 Million AUD as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Truscreen Group Ltd - Total Assets Trend (2013–2024)
This chart illustrates how Truscreen Group Ltd’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Truscreen Group Ltd - Asset Composition Analysis
Current Asset Composition (December 2024)
Truscreen Group Ltd's total assets of AU$4.30 Million consist of 83.4% current assets and 16.6% non-current assets.
| Asset Category | Amount (AUD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | AU$0.00 | 19.8% |
| Accounts Receivable | AU$433.81K | 23.5% |
| Inventory | AU$538.68K | 29.1% |
| Property, Plant & Equipment | AU$0.00 | 0.0% |
| Intangible Assets | AU$0.00 | 0.0% |
| Goodwill | AU$0.00 | 0.0% |
Asset Composition Trend (2013–2024)
This chart illustrates how Truscreen Group Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Truscreen Group Ltd's current assets represent 83.4% of total assets in 2024, an increase from 33.5% in 2013.
- Cash Position: Cash and equivalents constituted 19.8% of total assets in 2024, down from 24.7% in 2013.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 66.0% in 2013.
- Asset Diversification: The largest asset category is inventory at 29.1% of total assets.
Truscreen Group Ltd Competitors by Total Assets
Key competitors of Truscreen Group Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
|
China | CN¥5.17 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.67 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.10 Billion |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
|
UMediC Group Berhad
KLSE:0256
|
Malaysia | RM94.93 Million |
|
Osang Healthcare Co.,Ltd
KQ:036220
|
Korea | ₩287.70 Billion |
|
HansBiomed Corporation
KQ:042520
|
Korea | ₩126.41 Billion |
Truscreen Group Ltd - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Truscreen Group Ltd generates 0.93x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Truscreen Group Ltd is currently not profitable relative to its asset base.
Truscreen Group Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 5.05 | 2.68 | 6.74 |
| Quick Ratio | 4.28 | 1.88 | 6.12 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | AU$3.25 Million | AU$ 1.98 Million | AU$ 5.59 Million |
Truscreen Group Ltd - Advanced Valuation Insights
This section examines the relationship between Truscreen Group Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 13.06 |
| Latest Market Cap to Assets Ratio | 2.60 |
| Asset Growth Rate (YoY) | -54.1% |
| Total Assets | AU$1.85 Million |
| Market Capitalization | $4.80 Million USD |
Valuation Analysis
Premium Asset Valuation: The market values Truscreen Group Ltd's assets at a significant premium ( 2.60x), suggesting investors see substantial growth potential or unique competitive advantages.
Significant Asset Reduction: Truscreen Group Ltd's assets decreased by 54.1% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Truscreen Group Ltd (2013–2024)
The table below shows the annual total assets of Truscreen Group Ltd from 2013 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | AU$1.85 Million | -54.14% |
| 2023-12-31 | AU$4.03 Million | +16.14% |
| 2022-12-31 | AU$3.47 Million | -20.90% |
| 2021-12-31 | AU$4.39 Million | -63.46% |
| 2020-12-31 | AU$12.00 Million | +48.68% |
| 2019-12-31 | AU$8.07 Million | -35.64% |
| 2018-12-31 | AU$12.55 Million | +3.11% |
| 2017-12-31 | AU$12.17 Million | -19.11% |
| 2016-12-31 | AU$15.04 Million | +3.19% |
| 2015-12-31 | AU$14.58 Million | +36.93% |
| 2014-12-31 | AU$10.64 Million | -7.44% |
| 2013-12-31 | AU$11.50 Million | -- |